Michael Gee, MD, PhD
Read Bio
My research focuses on the development of new quantitative imaging biomarkers of active disease and treatment response prediction in inflammatory bowel disease and cancer, especially related to molecule-targeted therapies. These areas align with my clinical subspecialty training in pediatric radiology and abdominal imaging. I am particularly interested in the use of magnetic resonance imaging (MRI) and artificial intelligence (AI)/machine learning technologies to advance imaging biomarker development in these areas.
Recent Publications
Succi MD, Rao A, Gee MS, Coburn C, Brink JA Empowering Radiology's Future: A Proposed Leadership and Innovation Framework for a Radiology Department. J Am Coll Radiol. 2024;:ePub - PMID: 39096944 - DOI: 10.1016/j.jacr.2024.07.009
Shenoy-Bhangle A, Nimkin K, Gee MS Pediatric imaging: current and emerging techniques. J Postgrad Med. 2010;56(2):98-102 - PMID: 20622388 - DOI: 10.4103/0022-3859.65273
Peña-Trujillo V, Gallo-Bernal S, Kirsch J, Victoria T, Gee MS 3 Tesla Fetal MR Imaging Quality and Safety Considerations. Magn Reson Imaging Clin N Am. 2024;32(3):385-394 - PMID: 38944429 - DOI: 10.1016/j.mric.2024.02.007
Gee MS, Ghazani AA, Haq R, Wargo JA, Sebas M, Sullivan RJ, Lee H, Weissleder R Point of care assessment of melanoma tumor signaling and metastatic burden from μNMR analysis of tumor fine needle aspirates and peripheral blood. Nanomedicine. 2016;13(3):821-828 - PMID: 27993725 - PMCID: PMC5392428 - DOI: 10.1016/j.nano.2016.12.006
Kilcoyne A, Kaplan JL, Gee MS Inflammatory bowel disease imaging: Current practice and future directions. World J Gastroenterol. 2016;22(3):917-32 - PMID: 26811637 - PMCID: PMC4716045 - DOI: 10.3748/wjg.v22.i3.917
- More publications ...
